Inhibition or deficiency of ceramidase or SphK can sensitize DCs to ceramide-induced cell death, and tumor cells such as B16 melanoma release C16/24 ceramides and stimulate ceramide-induced apoptosis of DCs, attenuating DC-mediated lymphocyte activation120–122. The gene discussed is SPHK1; the disease is neoplasm.